Ryerson Exec Adds 25.5k Total RSUs after Dividend Accrual Filing

Rhea-AI Filing Summary

Ryerson Holding Corp. (RYI) – Form 4 insider filing

Executive Vice President & CFO James J. Claussen reported the automatic acquisition of dividend-equivalent 230.34 restricted stock units (RSUs) on 18 June 2025. These incremental units were credited to three existing RSU award pools, raising his holdings to 4,116.411, 8,050.99 and 13,320.38 RSUs, respectively (total ≈ 25,488 units). No cash changed hands (exercise price $0) and no common shares were sold. The newly accrued RSUs will vest in tranches on 31 Mar 2026-2028, mirroring the schedules of the underlying grants. The filing reflects routine dividend reinvestment mechanics rather than discretionary buying or selling, so the capital-markets impact is expected to be minimal.

Positive

• Increased management alignment: CFO’s equity stake rises by ~25.5 k RSUs, signalling continued long-term incentive alignment.

Negative

• Minor future dilution: Additional RSUs will convert to common stock upon vesting, incrementally expanding share count.

Insights

Financial Analyst

TL;DR: Routine dividend RSU accrual; negligible market impact, modest insider alignment.

The Form 4 discloses that CFO Claussen received 230.34 additional RSUs as dividend equivalents attached to prior awards. Transaction code “A” and $0 price confirm this is a non-cash, automatic issuance. While the update marginally increases potential dilution (<0.1 % of shares outstanding), it also strengthens management’s equity alignment. Because no open-market activity occurred and the quantities are small, the event is operationally neutral for investors.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Claussen James J

(Last) (First) (Middle)

C/O RYERSON HOLDING CORPORATION

227 W. MONROE ST., 27TH FLOOR

(Street)

CHICAGO IL 60606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ryerson Holding Corp [ RYI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President & CFO

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/18/2025		A		37.201(2)		(3)	(3)	Common Stock	37.201	$0	4,116.411	D
Restricted Stock Units	(1)	06/18/2025		A		72.759(2)		(4)	(4)	Common Stock	72.759	$0	8,050.99	D
Restricted Stock Units	(1)	06/18/2025		A		120.38(2)		(5)	(5)	Common Stock	120.38	$0	13,320.38	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company").

2. Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate.

3. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of June 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026.

4. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of June 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026 and March 31, 2027.

5. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of June 18, 2025. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2026, March 31, 2027 and March 31, 2028.

	/s/ Camilla Rykke Merrick, attorney-in-fact	06/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ryerson (RYI) report on the latest Form 4?

CFO James J. Claussen acquired 230.34 new RSUs via dividend-equivalent rights on 18 Jun 2025.

How many RSUs does the RYI CFO now own?

Post-transaction he beneficially owns approximately 25,488 RSUs across three grant tranches.

When will the newly accrued RSUs vest?

They will vest on 31 Mar 2026, 2027 and 2028, consistent with the underlying awards.

Was any cash paid or common stock sold in this transaction?

No. The RSUs were credited at $0 cost and no shares were sold.

Do dividend-equivalent RSUs cause dilution for RYI shareholders?

Yes, but the impact is immaterial; the 230-unit increase is a tiny fraction of Ryerson’s share count.